You found your accounts. Never miss their moment.
biofinder watches your target companies and tells you the day something changes: a funding round, a new trial, a new decision-maker. So you reach out while the budget is fresh, not a month after everyone else.
Funding signals first · one weekly digest · every event cited to source
Meridia Therapeutics
Raised a €14M Series A
Tessol Pharma
Opened six QC roles in Lyon
Veylor Bio
Signed a co-development deal
The timing play
Deals are won in the window
A raise, a new trial, a new decision-maker: each one opens a short window when the account is ready to talk. The only question is whether you show up at the start of it or at the end.
Day 0
The signal fires
A company on your watchlist closes a €14M round. The event lands in your feed the same day, cited to source.
Day 1
You're in their inbox
A sharp, relevant note while the raise is still news. You're the first vendor in the conversation, not the fortieth.
Day 7
The press release goes out
Now it's public knowledge. Every BD team in your niche reads the same announcement over coffee.
Day 35
The pile-on
The intro you would have sent joins a crowded inbox, a month late. This is where most outreach lives today.
What it watches
Every move that opens a door
Your watchlist is the set of accounts you want to win. Signals reads the market on every one of them, so a trigger event becomes your opening instead of old news.
Funding rounds
Live at launchThe clearest buying signal in life sciences. A target closes a round and you know that day: fresh budget, new plans, and a reason to be first in their inbox.
Meridia Therapeutics raised a €14M Series A
Today · cited to source · 2 contacts on file
New clinical trials
A sponsor moves into the clinic or starts a Phase II. New stage, new outsourcing demand.
Leadership changes
A new CSO or Head of CMC reviews every supplier relationship. A new door, and a natural reason to call.
L. Roussel joins as Head of CMC
Partnerships and deals
Licensing, co-development, acquisitions: the moves that redraw who buys from whom in your segment.
just signed together
Hiring signals
Headcount jumping in the functions you serve is a plan in motion, visible before any announcement.
Everything else that matters
Facility openings, certifications, approvals. If it changes the account, it fires; if it doesn't, it never reaches you.
How it works
Set it once. It watches for you.
No dashboard to babysit, no daily check-in. You build the list; biofinder does the watching and only speaks when there is something worth acting on.
Build your watchlist
One click per accountAdd target accounts in one click from any search, shortlist or company page. Your watchlist is the set of companies you want to win.
biofinder watches them
Weekly sweep by defaultIt sweeps every account on a schedule, checks each event against your criteria and drops the noise. You do nothing.
You get the moment
Silence when nothing movedA feed on the watchlist and one email digest when something fires. You reach out while the window is still open.
Delivery
Alerts you'll actually read. Not another inbox to manage.
You don't live inside biofinder every day, and you shouldn't have to. Signals come to you as a digest, and everything lands in the workspace where your shortlists and contacts already live.
- An event feed on every watchlist, grouped by company
- One email digest when something fires, never one email per event
- A badge on the bell next time you log in, nothing left to hunt for
biofinder Signals
This week: 2 events at your watched accounts
Meridia Therapeutics
Raised a €14M Series A · view source
Aubryn Pharma
Appointed a new Head of CMC · view source
Sent only because something fired. 36 other accounts: quiet.